Christophe M. Deroose

Society of Nuclear Medicine and Molecular Imaging — United States

Medicine · Health Sciences

47h-index9.4kcitations455works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(78), Neuroendocrine Tumor Research Advances(62), Radiomics and Machine Learning in Medical Imaging(61), Lung Cancer Research Studies(48), Radiopharmaceutical Chemistry and Applications(46)

Publications455 total

Can the 13C-octanoic acid breath test accurately measure gastric emptying after sleeve gastrectomy and Roux-en-Y gastric bypass? A proof-of concept analysis
Clinical Nutrition ESPEN·2025Open Access
Lead radionuclides for theranostic applications in nuclear medicine: from atom to bedside
Theranostics·2025Open Access
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges
Cancers·2025· 1 citedOpen Access
cGMP-compliant high-yield automated production of [18F]AlF-FAPI-74: optimization of quality control and evaluation of molar dose impact
EJNMMI Radiopharmacy and Chemistry·2025Open Access
First experience with intraperitoneal 224Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer
Gynecologic Oncology·2025Open Access
Relationship between [18F]PSMA-1007 PET parameters and biochemical recurrence-free survival in high-risk prostate cancer patients receiving neoadjuvant hormonal treatment
European Journal of Nuclear Medicine and Molecular Imaging·2025
Interreader agreement of intraprostatic prostate cancer detection, local extension and staging using [18F]PSMA-1007 PET and whole-mount radical prostatectomy specimens
European Urology Open Science·2025Open Access
Development & preclinical evaluation of [18F]AlF-3p-C-NETA-JR11, a promising Al18F-labeled SSTR2 antagonist for improved PET sensitivity
Nuclear Medicine and Biology·2025
Selective CXCR4-Targeting Antagonists Derived from LY2510924: [¹⁸F]AlF-NOTA-SC, [¹⁷⁷Lu]Lu-BL02, and [¹⁶¹Tb]Tb-BL02 as a Promising Trio for Precision Imaging and Therapy
Nuclear Medicine and Biology·2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR
European Radiology·2025Open Access
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors
Pharmaceuticals·2025Open Access
Extravasation of Therapeutic Radiopharmaceuticals: A Systematic Review and Management Proposal
Journal of Nuclear Medicine·2025
Reply to Taal et al. Comment on “Iasella et al. Close Follow-Up of Patients with Neurofibromatosis Type 1 Reduces the Incidence of Malignant Peripheral Nerve Sheath Tumour. Cancers 2025, 17, 1306”
Cancers·2025Open Access
[18F]MFBG PET/CT imaging of myocardial sympathetic innervation in healthy controls and patients with parkinson’s disease: dosimetry and pharmacokinetics
European Journal of Nuclear Medicine and Molecular Imaging·2025· 1 cited
Review for "Systematic review and meta‐analysis of the efficacy and safety of [ <sup>177</sup> <scp>Lu</scp> ]Lu‐edotreotide ([ <sup>177</sup> <scp>Lu</scp> ]Lu‐ <scp>DOTATOC</scp> ) for the treatment of neuroendocrine tumors"
2025
Role of FAPI PET/CT in cancer of unknown primary (CUP): A systematic review
European Journal of Radiology·2025· 3 cited
JAK/STAT inhibition protects glucocorticoid receptor knockout mice from lethal malaria-induced hypoglycemia and hyperinflammation
EMBO Molecular Medicine·2025· 1 citedOpen Access
Intra-individual comparison of PSMA PET and whole-body MRI in patients with biochemically recurrent prostate cancer
Clinical and Translational Imaging·2025
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol
BMJ Open·2025· 1 citedOpen Access
211P Retrospective analysis of liver transplantation eligibility based on the Milan criteria in patients with gastroenteropancreatic neuroendocrine tumors
Annals of Oncology·2025Open Access
page 1 of 23Next →

Frequent Co-authors

Guy Bormans(13), Frederik Cleeren(9), Johan Nuyts(6), Zeger Debyser(6), Karin Haustermans(6), Veerle Baekelandt(5), Koen Van Laere(5), Rik Gijsbers(5), Chris Verslype(5), Luc Mortelmans(4), Kris Bogaerts(4), Filip Calberson(4), Patrick Flamen(4), Vincent Vandecaveye(4), Kristof Baete(4), Elin Pauwels(4), Eric Van Cutsem(4), Michel Koole(4), Willy Gsell(4), Olivier Gheysens(3)